Recurrent Benign Lymphocytic Meningitis
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Recurrent benign lymphocytic meningitis is a recurring, typically innocuous, painful form of aseptic meningitis. This syndrome is associated with transient neurological symptoms in one-half of afflicted patients. The causative agent is usually herpes simplex virus type 2, which can be confirmed by detection of viral DNA in the cerebrospinal fluid using polymerase chain reaction. Clinical disease resolves spontaneously; however, acyclovir, valacyclovir, and famciclovir have been administered to some patients for both episodic therapy and suppression of recurrences. This therapy is thought to be beneficial, although there is no controlled trial data to support efficacy and safety.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Once-daily valacyclovir to reduce the risk of transmission of genital herpes.
Corey, L., Wald, A., Patel, R., Sacks, S. L., Tyring, S. K., Warren, T., Douglas, J. M., Paavonen, J., Morrow, R. A., Beutner, K. R., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035144 · Cited by 720
Whitley, R. J., & Lakeman, F. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.2.414 · Cited by 309 · cited 1×
“Historically, acyclovir has been used for treatment and suppression of HSV infection [29, 31, 32], and treatment of RBLM is no exception.”
BackgroundSelf-citationPrimary and Recurrent Herpes Simplex Virus Type 2-Induced Meningitis
Bergstrom, T., Vahlne, A., lestig, K., Jeansson, S., Forsgren, M., & Lycke, E. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.2.322 · Cited by 141 · cited 2×
“From the available case reports, we determined that RBLM is most frequently caused by HSV-2 and-much less frequently-by HSV- 1 [4, 9-17].”
BackgroundMertz, G. J. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440240109016 · Cited by 121
Treatment of Primary and Recurrent Herpes Simplex Virus Type 2 Induced Meningitis with Acyclovir
Bergström, T., & Alestig, K. (1990) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549009037909 · Cited by 52 · cited 2×
“Some investigators do not think acyclovir therapy alters the natural course of the illness [32].”
Background
Cited by
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
(2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-53488-0.00011-0 · Cited by 474
Logan, S. A. E., & MacMahon, E. (2008) · BMJ · doi:10.1136/bmj.39409.673657.ae · Cited by 219
Herpes simplex and varicella zoster CNS infections: clinical presentations, treatments and outcomes
Kaewpoowat, Q., Salazar, L., Aguilera, E., Wootton, S. H., & Hasbun, R. (2016) · Infection · doi:10.1007/s15010-015-0867-6 · Cited by 109
The Role of Antiviral Therapy in Immunocompromised Patients With Herpes Simplex Virus Meningitis
Noska, A., Kyrillos, R., Hansen, G., Hirigoyen, D., & Williams, D. N. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu772 · Cited by 45
“Although studies show that immunocompetent hosts with HSV meningitis typically improve with or without specific antiviral therapy [2, 5–6, 15, 21–22], neurologic recovery appears to be less favorable, with an increased likelihood of sequelae in immunocompromised patients.”
BackgroundNeurology of Acute Viral Infections
Krett, J. D., Beckham, J. D., Tyler, K. L., Piquet, A. L., Chauhan, L., Wallace, C. J., Pastula, D. M., & Kapadia, R. K. (2022) · The Neurohospitalist · doi:10.1177/19418744221104778 · Cited by 13
Metadata
- Authors
- Shalabi, M., & Whitley, R. J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-11-01
- Volume
- 43
- Issue
- 9
- Pages
- 1194-1197
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2134582169
- Cited by
- 103
- References
- 5
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.